“Persistent Supravenous Erythematous Eruption (PSEE): A scoping review on an adverse effect related to Docetaxel infusion”, RSD, vol. 11, no. 5, p. e21111527974, Apr. 2022, doi: 10.33448/rsd-v11i5.27974.